The purpose of this concept analysis is to clarify and analyze the concept of self-care. Self-care is vital in the prevention, control, and management of chronic disease. It is substantially important in all aspects of health and all levels of care, and it is key to chronic disease management. Walker and Avant's (2011) method for concept analysis was used. A literature search was performed using the Cumulative Index to Nursing and Allied Health Literature, Psych INFO, Cochrane Library, Embase, Medline, and Google Scholar databases for relevant articles published between 2000 and 2020 using the search terms self-care, chronic illness, and chronic disease. A total of 22 articles were found for the final analysis. The three defining attributes of self-care include readiness, ability, and activity/practice. Similarly, antecedents (illness/treatment, health systems, and environment) and consequences (health status improvement and wellbeing-related, symptom management-related, cost reduction-related, and personal development-related) of self-care were derived from literature. Constructed cases were created to illustrate these aspects of self-care. Through this concept analysis, the complexity and breadth of the self-care concept are elucidated.

Download full-text PDF

Source
http://dx.doi.org/10.1111/nuf.12577DOI Listing

Publication Analysis

Top Keywords

chronic disease
16
concept analysis
16
self-care concept
12
self-care
8
concept
6
chronic
5
analysis
5
disease self-care
4
analysis purpose
4
purpose concept
4

Similar Publications

Objectives: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide, particularly among the elderly, resulting in high rates of intensive care unit (ICU) admissions. Malnutrition is common in elderly patients and has been associated with poor prognosis in patients with COPD. However, its impact in the ICU setting remains incompletely defined.

View Article and Find Full Text PDF

Background: Tuberculosis (TB) remains a significant global health issue. Drug-resistant TB and comorbidities exacerbate its burden, influencing treatment outcomes and healthcare utilization. Despite the growing prevalence of TB comorbidities, research often focuses on single comorbidities rather than comorbidity patterns.

View Article and Find Full Text PDF

Associations between ABO, FUT2 and chronic pancreatitis: A comprehensive meta-analysis of multiple cohorts and public biobanks.

Pancreatology

December 2024

Department of Gastroenterology, National Clinical Research Center for Digestive Diseases, Changhai Hospital, Naval Medical University, Shanghai, 200433, China. Electronic address:

Objectives: Associations of ABO blood group specifying transferases A/B (ABO) and fucosyltransferase 2 (FUT2) with CP remain inconclusive. We aimed to comprehensively investigate the associations by Chinese sequencing cohorts and external cohorts.

Methods: First, we analyzed the distributions of ABO blood groups and FUT2 status, along with lead single nucleotide polymorphisms (SNPs) at ABO (rs8176693 C/T) and FUT2 (rs632111 A/G) gene loci in Chinese low-coverage whole-genome sequencing discovery cohort.

View Article and Find Full Text PDF

Updates on the Pathogenesis of Canine Atopic Dermatitis and Feline Atopic Skin Syndrome: Part 2, the Skin Barrier, the Microbiome, and Immune System Dysfunction.

Vet Clin North Am Small Anim Pract

December 2024

College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, 408 Raymond Stotzer Parkway, College Station, TX 77845, USA. Electronic address:

Alterations in the lipid layer and intercellular corneocyte connections can lead to increased allergen penetration through the skin surface. A normal cutaneous microbiome keeps the opportunistic pathogen Staphylococcus pseudintermedius levels low, but allergic inflammation leads to decreased diversity and increase in S pseudintermedius. Keratinocytes sound the initial allergen alarm via cytokine signaling and promote T-helper 2 (Th-2) inflammation.

View Article and Find Full Text PDF

In the past decade, the treatment paradigm for chronic lymphocytic leukemia (CLL) has markedly shifted from traditional chemoimmunotherapy towards targeted therapies. A fixed-duration, targeted regimen with venetoclax, a potent oral BCL-2 inhibitor, combined with obinutuzumab, a glycoengineered type II anti-CD20 monoclonal antibody (Ven-Obi), has become the standard to beat for time-limited therapy in CLL. Ven-Obi allows for the rapid induction of remissions with high rates of undetectable minimal residual disease (uMRD) in patients across different treatment settings.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!